DAFNA Capital Management as of Dec. 31, 2017
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 72 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 13.4 | $25M | 296k | 84.18 | |
Blueprint Medicines (BPMC) | 4.1 | $7.6M | 101k | 75.41 | |
AtriCure (ATRC) | 3.8 | $7.1M | 389k | 18.24 | |
Aerie Pharmaceuticals | 3.8 | $7.0M | 117k | 59.75 | |
Argenx Se (ARGX) | 3.2 | $6.0M | 95k | 63.14 | |
Beigene (BGNE) | 3.2 | $6.0M | 61k | 97.72 | |
BioCryst Pharmaceuticals (BCRX) | 3.2 | $5.9M | 1.2M | 4.91 | |
Zogenix | 2.9 | $5.4M | 134k | 40.05 | |
NxStage Medical | 2.8 | $5.2M | 216k | 24.23 | |
Ascendis Pharma A S (ASND) | 2.7 | $5.0M | 125k | 40.06 | |
Immunomedics | 2.6 | $4.9M | 304k | 16.16 | |
Dex (DXCM) | 2.6 | $4.8M | 83k | 57.39 | |
Sage Therapeutics (SAGE) | 2.5 | $4.7M | 29k | 164.72 | |
Vbi Vaccines | 2.3 | $4.3M | 998k | 4.27 | |
Neurocrine Biosciences (NBIX) | 2.3 | $4.2M | 55k | 77.58 | |
Alder Biopharmaceuticals | 2.1 | $4.0M | 346k | 11.45 | |
Rigel Pharmaceuticals | 2.0 | $3.8M | 984k | 3.88 | |
Radius Health Inc note 3.000% 9/0 | 2.0 | $3.8M | 4.0M | 0.94 | |
Galapagos Nv- (GLPG) | 2.0 | $3.7M | 40k | 93.77 | |
Cymabay Therapeutics | 1.8 | $3.3M | 361k | 9.20 | |
Macrogenics (MGNX) | 1.6 | $2.9M | 154k | 19.00 | |
Sunesis Pharmaceuticals Inc Ne | 1.6 | $2.9M | 783k | 3.69 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.5 | $2.8M | 26k | 106.78 | |
Achillion Pharmaceuticals | 1.5 | $2.7M | 948k | 2.88 | |
Biotelemetry | 1.4 | $2.6M | 88k | 29.90 | |
Voyager Therapeutics (VYGR) | 1.4 | $2.6M | 157k | 16.60 | |
Dermira | 1.3 | $2.4M | 86k | 27.81 | |
Insulet Corporation (PODD) | 1.2 | $2.2M | 33k | 68.99 | |
Foamix Pharmaceuticals | 1.1 | $2.1M | 353k | 6.01 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.1 | $2.1M | 2.5M | 0.85 | |
Akebia Therapeutics (AKBA) | 1.1 | $2.0M | 136k | 14.87 | |
Aeglea Biotherapeutics | 1.0 | $1.9M | 350k | 5.41 | |
Ardelyx (ARDX) | 1.0 | $1.8M | 275k | 6.60 | |
Kura Oncology (KURA) | 1.0 | $1.8M | 117k | 15.30 | |
Radius Health | 0.9 | $1.7M | 53k | 31.78 | |
Dermira Inc note 3.000% 5/1 | 0.9 | $1.7M | 1.5M | 1.10 | |
Applied Genetic Technol Corp C | 0.8 | $1.5M | 421k | 3.60 | |
Insulet Corp note 1.375% | 0.8 | $1.5M | 1.5M | 1.01 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.8 | $1.5M | 216k | 6.80 | |
Aquinox Pharmaceuticals | 0.8 | $1.4M | 119k | 11.76 | |
Exactech | 0.7 | $1.4M | 28k | 49.43 | |
Johnson & Johnson (JNJ) | 0.7 | $1.3M | 9.4k | 139.68 | |
Immune Design | 0.7 | $1.3M | 329k | 3.90 | |
Scpharmaceuticals (SCPH) | 0.6 | $1.2M | 98k | 12.09 | |
Scynexis | 0.6 | $1.2M | 507k | 2.32 | |
ArQule | 0.6 | $1.2M | 697k | 1.65 | |
Cara Therapeutics (CARA) | 0.6 | $1.1M | 94k | 12.24 | |
Clementia | 0.6 | $1.1M | 60k | 18.98 | |
Stereotaxis (STXS) | 0.6 | $1.1M | 1.4M | 0.80 | |
Xenon Pharmaceuticals (XENE) | 0.6 | $1.1M | 378k | 2.83 | |
Minerva Neurosciences | 0.6 | $1.0M | 171k | 6.05 | |
Cogentix Medical | 0.6 | $1.0M | 324k | 3.15 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.4 | $743k | 231k | 3.22 | |
Advaxis | 0.4 | $702k | 247k | 2.84 | |
Proteostasis Therapeutics In | 0.4 | $685k | 118k | 5.83 | |
Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.4 | $670k | 573k | 1.17 | |
Leap Therapeutics | 0.4 | $676k | 108k | 6.24 | |
BioTime | 0.3 | $591k | 275k | 2.15 | |
Luminex Corporation | 0.3 | $493k | 25k | 19.72 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.2 | $450k | 600k | 0.75 | |
Masimo Corporation (MASI) | 0.2 | $424k | 5.0k | 84.80 | |
Cascadian Therapeutics | 0.2 | $395k | 107k | 3.70 | |
Bluebird Bio (BLUE) | 0.2 | $356k | 2.0k | 178.00 | |
Natus Medical | 0.2 | $302k | 7.9k | 38.23 | |
Neos Therapeutics | 0.1 | $281k | 28k | 10.22 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.1 | $235k | 250k | 0.94 | |
Deciphera Pharmaceuticals | 0.1 | $218k | 9.6k | 22.66 | |
Redhill Biopharma Ltd cmn | 0.1 | $180k | 35k | 5.14 | |
Edge Therapeutics | 0.1 | $182k | 19k | 9.38 | |
Bellicum Pharma | 0.1 | $168k | 20k | 8.40 | |
Obseva Sa | 0.1 | $139k | 14k | 9.77 | |
Spero Therapeutics (SPRO) | 0.0 | $59k | 5.0k | 11.80 |